News · 26 weeks37-76%
2025-10-262026-04-19
Mix2490d
- Insider13(54%)
- SEC Filings6(25%)
- Other3(13%)
- Earnings2(8%)
Latest news
25 items- PRPrivia Health to Report First Quarter 2026 Results on Thursday, May 7ARLINGTON, Va., April 08, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its first quarter ended March 31, 2026 before market open on Thursday, May 7, 2026. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, May 7, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/events-and-presentations to li
- INSIDERSEC Form 4 filed by Mountcastle David4 - Privia Health Group, Inc. (0001759655) (Issuer)
- SECSEC Form DEFA14A filed by Privia Health Group Inc.DEFA14A - Privia Health Group, Inc. (0001759655) (Filer)
- SECSEC Form DEF 14A filed by Privia Health Group Inc.DEF 14A - Privia Health Group, Inc. (0001759655) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Privia Health Group Inc.SCHEDULE 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
- PRPrivia Health Earns 2026 HFMA MAP Award for Revenue Cycle ExcellenceARLINGTON, Va., March 24, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced that its network of affiliated medical groups, collectively Privia Medical Group, has been named a recipient of the 2026 MAP (Measure, Apply, Perform) Award for High Performance in Revenue Cycle, sponsored by the Healthcare Financial Management Association (HFMA). Privia Health has been recognized by HFMA for its revenue cycle capabilities and performance in nine of the last ten years. The MAP Award is one of the healthcare industry's most respected distinctions, highlighting organizations that demonstrate sustained excellence across key revenue cycle metrics, including net collection rat
- INSIDERSEC Form 4 filed by Mountcastle David4 - Privia Health Group, Inc. (0001759655) (Issuer)
- INSIDERSEC Form 4 filed by Mehrotra Parth4 - Privia Health Group, Inc. (0001759655) (Issuer)
- INSIDEREVP & Chief Financial Officer Mountcastle David sold $282,600 worth of shares (13,018 units at $21.71), decreasing direct ownership by 5% to 226,804 units (SEC Form 4)4 - Privia Health Group, Inc. (0001759655) (Issuer)
- INSIDERChief Executive Officer Mehrotra Parth sold $1,172,078 worth of shares (53,992 units at $21.71), decreasing direct ownership by 8% to 581,952 units (SEC Form 4)4 - Privia Health Group, Inc. (0001759655) (Issuer)
- INSIDERChief Executive Officer Mehrotra Parth sold $479,113 worth of shares (21,097 units at $22.71) and was granted 313,246 shares, increasing direct ownership by 85% to 635,944 units (SEC Form 4)4 - Privia Health Group, Inc. (0001759655) (Issuer)
- INSIDEREVP & General Counsel Fargis Edward C was granted 28,268 shares, increasing direct ownership by 34% to 111,979 units (SEC Form 4)4 - Privia Health Group, Inc. (0001759655) (Issuer)
- INSIDEREVP & Chief Financial Officer Mountcastle David was granted 77,919 shares, increasing direct ownership by 48% to 239,822 units (SEC Form 4)4 - Privia Health Group, Inc. (0001759655) (Issuer)
- SECSEC Form 144 filed by Privia Health Group Inc.144 - Privia Health Group, Inc. (0001759655) (Subject)
- INSIDERChief Executive Officer Mehrotra Parth sold $1,456,239 worth of shares (63,439 units at $22.95), decreasing direct ownership by 16% to 343,795 units (SEC Form 4)4 - Privia Health Group, Inc. (0001759655) (Issuer)
- INSIDEREVP & General Counsel Fargis Edward C sold $214,756 worth of shares (9,343 units at $22.99), decreasing direct ownership by 10% to 83,711 units (SEC Form 4)4 - Privia Health Group, Inc. (0001759655) (Issuer)
- INSIDEREVP & Chief Financial Officer Mountcastle David sold $252,982 worth of shares (11,006 units at $22.99), decreasing direct ownership by 6% to 161,903 units (SEC Form 4)4 - Privia Health Group, Inc. (0001759655) (Issuer)
- SECSEC Form 144 filed by Privia Health Group Inc.144 - Privia Health Group, Inc. (0001759655) (Subject)
- PRMarking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry CollaborationAmalgam Rx, Inc., Privia Health, and Exact Sciences Corp. highlight how coordinated, EHR-enabled patient outreach supported measurable screening impact at scale. Amalgam Rx, Inc., a leader in data-driven, AI-powered healthcare engagement and clinical decision support, today announced results from a Privia Health (NASDAQ:PRVA)-led colorectal cancer (CRC) screening program, supported by Amalgam Rx, Inc. and Exact Sciences Corp. (NASDAQ:EXAS). Documented in a published Privia Health case study, the program demonstrates how EHR-integrated workflows and proactive patient outreach supported an increase of CRC screening rates to 84% in 2024, exceeding national benchmarks and surpassing the Natio
- INSIDEREVP & Chief Financial Officer Mountcastle David exercised 13,058 shares at a strike of $2.00 and sold $326,835 worth of shares (13,058 units at $25.03) (SEC Form 4)4 - Privia Health Group, Inc. (0001759655) (Issuer)
- INSIDERDirector Morris Matthew Shawn exercised 24,338 shares at a strike of $2.00 and sold $608,372 worth of shares (24,338 units at $25.00) (SEC Form 4)4 - Privia Health Group, Inc. (0001759655) (Issuer)
- SECSEC Form 10-K filed by Privia Health Group Inc.10-K - Privia Health Group, Inc. (0001759655) (Filer)
- SECPrivia Health Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Privia Health Group, Inc. (0001759655) (Filer)
- PRPrivia Health Reports Fourth Quarter and Full-Year 2025 Financial ResultsAll 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year 2025 Net Cash Provided by Operating Activities of $163.4 Million, +49.5% from 2024; Year-end 2025 Cash Balance of $479.7 Million and No Debt2026 Guidance Reflects ~20% Adjusted EBITDA Growth at Midpoint ARLINGTON, Va., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2025. Each of the Company's operating and financial performance metrics were at or above the high end
- PRPrivia Health to Report Fourth Quarter 2025 Results on Thursday, February 26ARLINGTON, Va., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its fourth-quarter and twelve-month periods ended December 31, 2025 before market open on Thursday, February 26, 2026. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, February 26, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-a